Lymphastat Liquid
Product Images NDC 44911-0615

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Lymphastat (NDC 44911-0615). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Energique, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lymphastat (Enrg125 Lymphastat 1oz 4 8 21)

Lymphastat (Enrg125 Lymphastat 1oz 4 8 21)
This product, Lymphastat, may help temporarily alleviate symptoms associated with viral and bacterial infections, including fever, irritated throat, and cough with a tickle in the throat. The directions indicate that adults and children can take 5 to 10 drops orally, three times daily, or as directed by a healthcare professional. It is important to consult a physician if using this product on children under the age of 12, or if symptoms persist for more than two days. The warning advises individuals to consult a physician if experiencing severe or persistent sore throat, or sore throat with associated symptoms, such as high fever, headache, nausea, and vomiting. It is also recommended to store this product in a cool and dry place, and to keep it out of reach of children. This product's claims are based on traditional homeopathic practice and have not been evaluated by the FDA.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.